Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 2 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

0
Player Avatar physdude (< 20) Submitted: 1/25/2013 4:05:36 AM : Outperform Start Price: $24.84 QCOR Score: +193.18

It is being pushed down by false rumors and will recover once their effect is over.

Featured Broker Partners


Advertisement